P50CA098252/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2006	1
2007	3
2008	2
2009	2
2010	1
2011	2
2012	4
2013	9
2014	14
2015	9
2016	1
2018	1
2020	1
2021	1
2022	1
2024	0

1

Zhao RX, Xu ZX. Zhao RX, et al. Curr Drug Targets. 2014 Jan;15(1):32-52. doi: 10.2174/1389450114666140106095811. Curr Drug Targets. 2014. PMID: 24387336 Free PMC article. Review.

2

Identification of human MHC-I HPV18 E6/E7-specific CD8 + T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice.

Peng S, Xing D, Ferrall L, Tsai YC, Hung CF, Wu TC. Peng S, et al. J Biomed Sci. 2022 Oct 12;29(1):80. doi: 10.1186/s12929-022-00864-5. J Biomed Sci. 2022. PMID: 36224625 Free PMC article.

3

Recent advances in the study of HPV-associated carcinogenesis.

Jin L, Xu ZX. Jin L, et al. Virol Sin. 2015 Apr;30(2):101-6. doi: 10.1007/s12250-015-3586-3. Epub 2015 Apr 20. Virol Sin. 2015. PMID: 25910482 Free PMC article. Review.

4

New approaches to prophylactic human papillomavirus vaccines for cervical cancer prevention.

Gersch ED, Gissmann L, Garcea RL. Gersch ED, et al. Antivir Ther. 2012;17(3):425-34. doi: 10.3851/IMP1941. Epub 2011 Nov 7. Antivir Ther. 2012. PMID: 22293302 Free PMC article. Review.

5

Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases.

Olczak P, Roden RBS. Olczak P, et al. Vaccines (Basel). 2020 Oct 1;8(4):568. doi: 10.3390/vaccines8040568. Vaccines (Basel). 2020. PMID: 33019516 Free PMC article. Review.

6

Immunological research using RNA interference technology.

Mao CP, Lin YY, Hung CF, Wu TC. Mao CP, et al. Immunology. 2007 Jul;121(3):295-307. doi: 10.1111/j.1365-2567.2007.02599.x. Epub 2007 Apr 12. Immunology. 2007. PMID: 17428313 Free PMC article. Review.

7

Immunotherapeutic strategies employing RNA interference technology for the control of cancers.

Mao CP, Hung CF, Wu TC. Mao CP, et al. J Biomed Sci. 2007 Jan;14(1):15-29. doi: 10.1007/s11373-006-9131-5. Epub 2006 Nov 14. J Biomed Sci. 2007. PMID: 17103251 Review.

8

Development of a highly thermostable, adjuvanted human papillomavirus vaccine.

Hassett KJ, Meinerz NM, Semmelmann F, Cousins MC, Garcea RL, Randolph TW. Hassett KJ, et al. Eur J Pharm Biopharm. 2015 Aug;94:220-8. doi: 10.1016/j.ejpb.2015.05.009. Epub 2015 May 18. Eur J Pharm Biopharm. 2015. PMID: 25998700 Free PMC article.

9

Piperlongumine induces autophagy by targeting p38 signaling.

Wang Y, Wang JW, Xiao X, Shan Y, Xue B, Jiang G, He Q, Chen J, Xu HG, Zhao RX, Werle KD, Cui R, Liang J, Li YL, Xu ZX. Wang Y, et al. Cell Death Dis. 2013 Oct 3;4(10):e824. doi: 10.1038/cddis.2013.358. Cell Death Dis. 2013. PMID: 24091667 Free PMC article.

10

Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States.

Ojha RP, Jackson BE, Tota JE, Offutt-Powell TN, Singh KP, Bae S. Ojha RP, et al. Hum Vaccin Immunother. 2014;10(1):232-7. doi: 10.4161/hv.26292. Epub 2013 Sep 6. Hum Vaccin Immunother. 2014. PMID: 24013368 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

43 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year